IMPRINT (intensity-modulated pleural radiation therapy) is showing promise as part of a multidisciplinary approach to treating pleural mesothelioma. This type of radiation therapy helps [...]
The National Comprehensive Cancer Network (NCCN) has recently changed its mesothelioma treatment guidelines to help improve patient life expectancy. Adding the monoclonal antibody bevacizumab to [...]
P2RX7 is a protein-coding gene that is expressed by mesothelioma cancer cells. A new study is looking into medications that might block P2X7R and inhibit [...]
A recently identified blood biomarker, activin A, may prove useful in the early detection of mesothelioma. Equally promising, this new biomarker may even allow [...]
